Fertility

The Embryology Lab Matters More Than the Lobby

Save

Clinics compete on the things you can see — the waiting room, the concierge, the brochure. But an IVF cycle succeeds or fails in a room most patients never enter, where embryologists fertilize, culture, grade, and freeze embryos by hand. This is what the lab actually does, why its quality quietly decides your odds, and how to judge one when you can't watch it work.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Why the lab, not the lobby, decides your cycle

The embryology lab is the single place in a fertility clinic where the biology of IVF actually happens, which makes it the part most worth judging. Everything a patient experiences — the consultation, the waiting room, the app — sits outside the room where eggs meet sperm and embryos grow. Clinics report their outcomes into a national system that publishes results clinic by clinic and by age band 1, and those results are produced in the lab, not the lobby. an IVF cycle is won or lost in the lab, not the lobby

This is not a claim that doctors, nurses, and coordinators don't matter; they do. It is a claim about where a cycle is won or lost. Two clinics with identical brochures can have very different laboratories, and the difference does not show up on a tour. So when the marketing draws your eye to amenities, the useful instinct is to look past them, toward the bench work you cannot see.

What actually happens in the embryology lab

Inside the lab, embryologists carry out the steps that turn retrieved eggs into a transferable embryo: fertilizing the eggs — either by mixing them with sperm or, when indicated, injecting a single sperm into each — then culturing them for several days, grading how they develop, and freezing what is not transferred. Some labs also biopsy embryos for genetic testing. Each step depends on technique, timing, and a tightly controlled environment.

This is why lab quality is not abstract. Air quality, temperature, the media embryos grow in, and the skill of the hands doing the work all shape whether an embryo survives to day five and survives a thaw. The lab can also only work with the eggs it is given — the question of egg quality vs quantity sets a ceiling the lab cannot exceed. Some steps are where optional add-ons are sold: preimplantation genetic testing for aneuploidy, or PGT-A, is a lab procedure that has not been shown to raise live-birth rates for the general patient 2, and time-lapse imaging of embryos is another lab add-on rated as unproven 3. A long lab menu is not the same as a strong lab.

Why a good lab makes single-embryo transfer possible

One of the clearest signs of a capable lab is that it lets a clinic transfer just one embryo at a time. Growing embryos reliably to the blastocyst stage and freezing and thawing them without damage is what makes elective single-embryo transfer practical. That matters because multiple gestation is the main avoidable risk of fertility treatment, carrying higher risks of preterm birth, low birth weight, and maternal complications 4. elective single-embryo transfer matches cumulative success with far lower twin risk 5

Guidance recommends single-embryo transfer precisely because moving one embryo achieves cumulative success comparable to transferring several, with far lower twin risk 5. A lab that cannot freeze and thaw dependably pushes a clinic toward transferring more embryos to compensate — which can lift a per-transfer number while quietly raising the odds of a riskier twin pregnancy. In that sense a lab's weakness becomes the patient's medical risk, which is why the lab's freezing and single-transfer practices are worth asking about directly.

The lab is where unproven add-ons live

Many of the extras that inflate an IVF bill are lab procedures, so the lab is also where evidence and marketing collide most. Assisted hatching, time-lapse imaging, and add-on genetic tests are all performed at the bench, and most such add-ons are rated as lacking good evidence of benefit 3. Routine PGT-A, in particular, has not been shown to improve live-birth rates for the general IVF population 2.

The reason this belongs in a discussion of the lab is that a slick, high-tech laboratory can look impressive precisely because it offers a full slate of these fertility add-ons the evidence doesn't support. Sophistication is easy to display and hard to evaluate. The better signal is not how many add-ons a lab performs but whether it can justify each one for your specific case — and whether its core work, the fertilizing and culturing and freezing, is done to a consistent standard.

How to judge a lab you can't watch

Because you will never see the lab work, you judge it by proxy. The strongest proxies are lab accreditation, the clinic's single-embryo-transfer rate, its approach to freezing and thaw survival, and how openly it explains its grading and its results. A structured way to bring these into a consultation is a shared-decision-making method: the AHRQ SHARE approach lays out five steps — seek your participation, help you compare options, assess what matters to you, reach a decision together, and evaluate it 6. SHARE approach — a five-step model for making a decision together with your clinician 6

Used that way, a short list of embryology lab questions turns an invisible service into something you can weigh: what accreditation the lab holds, how it handles freezing and thawing, how it decides day-three versus day-five transfer, and which add-ons it recommends and why. You are not trying to become an embryologist. You are trying to see whether the people running the room can explain their standards plainly — and a lab that answers openly is telling you something a lobby never can.

Weigh the lab first, the amenities last

Put together, the lesson is an ordering of priorities. The lobby, the concierge, and the app are real conveniences, but they do not touch an embryo. The lab and the clinicians do. When you research a fertility clinic near you, start with its published outcomes in your own age band 1, then ask which of its lab procedures are actually evidence-based, and treat the amenities as the tiebreaker they are — pleasant, but not predictive.

None of this means a comfortable clinic is a bad one; comfort and competence can coexist. It means comfort is not evidence. The questions that predict your outcome are about the bench: how embryos are fertilized, cultured, graded, and frozen, and how honestly the clinic reports what happens after. A fuller way to weigh value is the cost per live birth rather than the price of a single cycle. Ask the bench questions first — a beautiful waiting room paired with an evasive answer about the lab is a clinic that has spent its money where you can see it, not where it counts.

Common questions

Both matter, but they do different jobs. The physician sets the plan and performs the retrieval and transfer; the lab keeps the eggs and embryos alive and growing in between, which is where most of the biology happens. A skilled doctor cannot rescue a cycle from a lab that cultures or freezes embryos poorly. The two are a team, and the lab is the half patients most often overlook.

Rarely, and for good reason — labs keep tightly controlled air, temperature, and sterility, so foot traffic is limited. That is why you judge a lab indirectly: by its accreditation, its single-embryo-transfer and freezing practices, and how clearly staff answer your questions. An unwillingness to discuss the lab's standards at all is more telling than not being allowed to walk through it.

Ask what accreditation the lab holds, how it handles freezing and thaw survival, how it decides between a day-three and day-five transfer, and which add-ons it recommends and why. Clear, specific answers suggest a lab that knows its own numbers. Vague reassurance or a pivot to amenities suggests the opposite. You are testing openness as much as any single fact.

Not reliably. Many add-ons — time-lapse imaging, assisted hatching, routine genetic testing — are rated as unproven, so a full menu can signal marketing rather than skill. The core work of fertilizing, culturing, grading, and freezing embryos is what drives the outcome. A lab that does the basics consistently and can justify any extra for your case is a better sign than a long list of impressive-sounding services.

A strong lab can grow embryos to the blastocyst stage and freeze and thaw them dependably, which makes transferring a single embryo practical without lowering your overall chances. A weaker lab may push toward transferring more embryos to compensate, raising the risk of twins. So a clinic's single-embryo-transfer rate is partly a readout of its laboratory's strength.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Judging a lab is about competence, not comfort

  • —A clinic that markets amenities heavily but gives vague or evasive answers about the lab's accreditation and freezing practices.
  • —A lab that recommends several unproven add-ons as standard without a specific reason tied to your case.
  • —A high pregnancy-per-transfer rate paired with a high multiple-birth rate, suggesting more embryos are being transferred to compensate.

This article explains why the embryology lab matters and how to evaluate one; it is general information, not medical advice. It names no clinic or lab. Whether a given clinic fits your needs depends on your diagnosis and history, which a reproductive endocrinologist can assess.

References

  1. 1.Society for Assisted Reproductive Technology (SART) (2024). National Summary Report (SART CORS Online). Society for Assisted Reproductive Technology. link ✓That IVF outcomes are reported into a national system, clinic by clinic and by patient age band — the aggregate data patients can read, not any single clinic's marketing claim.
  2. 2.Practice Committees of ASRM and SART (2024). The use of preimplantation genetic testing for aneuploidy: a committee opinion. American Society for Reproductive Medicine (Fertility and Sterility). PMID 38762806 ✓That routine PGT-A, a lab procedure, has not been shown to raise live-birth rates for the general IVF patient.
  3. 3.Human Fertilisation and Embryology Authority (2024). Treatment add-ons with limited evidence. Human Fertilisation and Embryology Authority (UK). link ✓That most marketed IVF add-ons performed in the lab — such as time-lapse imaging and assisted hatching — are rated as lacking good evidence of benefit.
  4. 4.Practice Committee of ASRM and SART (2022). Multiple gestation associated with infertility therapy: a committee opinion. American Society for Reproductive Medicine (Fertility and Sterility). linkThat multiple gestation is the principal avoidable risk of infertility therapy, carrying higher maternal and neonatal risk, and is reduced by conservative embryo numbers and single-embryo transfer.
  5. 5.Practice Committees of ASRM and SART (2021). Guidance on the limits to the number of embryos to transfer: a committee opinion. American Society for Reproductive Medicine (Fertility and Sterility). linkThat elective single-embryo transfer achieves cumulative success comparable to transferring several embryos, with far lower twin risk — which a capable lab's reliable freezing makes practical.
  6. 6.Agency for Healthcare Research and Quality (2020). The SHARE Approach. Agency for Healthcare Research and Quality (AHRQ). link ✓The five steps of AHRQ's SHARE Approach to shared decision making — Seek, Help, Assess, Reach, and Evaluate — a structure for weighing options with a clinician.

6 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy

← Back to the health library